BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10074197)

  • 1. Systemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII mice.
    Stein CS; Ghodsi A; Derksen T; Davidson BL
    J Virol; 1999 Apr; 73(4):3424-9. PubMed ID: 10074197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse.
    Sferra TJ; Backstrom K; Wang C; Rennard R; Miller M; Hu Y
    Mol Ther; 2004 Sep; 10(3):478-91. PubMed ID: 15336648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated gene transfer and expression of human beta-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice.
    Ohashi T; Watabe K; Uehara K; Sly WS; Vogler C; Eto Y
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1287-92. PubMed ID: 9037045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse.
    Sferra TJ; Qu G; McNeely D; Rennard R; Clark KR; Lo WD; Johnson PR
    Hum Gene Ther; 2000 Mar; 11(4):507-19. PubMed ID: 10724030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer.
    Li T; Davidson BL
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7700-4. PubMed ID: 7644479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive beta-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain.
    Ghodsi A; Stein C; Derksen T; Yang G; Anderson RD; Davidson BL
    Hum Gene Ther; 1998 Nov; 9(16):2331-40. PubMed ID: 9829532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system delivery of helper-dependent canine adenovirus corrects neuropathology and behavior in mucopolysaccharidosis type VII mice.
    Ariza L; Giménez-Llort L; Cubizolle A; Pagès G; García-Lareu B; Serratrice N; Cots D; Thwaite R; Chillón M; Kremer EJ; Bosch A
    Hum Gene Ther; 2014 Mar; 25(3):199-211. PubMed ID: 24299455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer.
    Ghodsi A; Stein C; Derksen T; Martins I; Anderson RD; Davidson BL
    Exp Neurol; 1999 Nov; 160(1):109-16. PubMed ID: 10630195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII.
    Bielicki J; McIntyre C; Anson DS
    Mol Genet Metab; 2010 Dec; 101(4):370-82. PubMed ID: 20864369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.
    Stein CS; Kang Y; Sauter SL; Townsend K; Staber P; Derksen TA; Martins I; Qian J; Davidson BL; McCray PB
    Mol Ther; 2001 Jun; 3(6):850-6. PubMed ID: 11407898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors.
    Brooks AI; Stein CS; Hughes SM; Heth J; McCray PM; Sauter SL; Johnston JC; Cory-Slechta DA; Federoff HJ; Davidson BL
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6216-21. PubMed ID: 11959904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells.
    Ross CJ; Bastedo L; Maier SA; Sands MS; Chang PL
    Hum Gene Ther; 2000 Oct; 11(15):2117-27. PubMed ID: 11044913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread correction of lysosomal storage in the mucopolysaccharidosis type VII mouse brain with a herpes simplex virus type 1 vector expressing beta-glucuronidase.
    Berges BK; Yellayi S; Karolewski BA; Miselis RR; Wolfe JH; Fraser NW
    Mol Ther; 2006 May; 13(5):859-69. PubMed ID: 16515890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.
    Daly TM; Okuyama T; Vogler C; Haskins ME; Muzyczka N; Sands MS
    Hum Gene Ther; 1999 Jan; 10(1):85-94. PubMed ID: 10022533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.
    Frisella WA; O'Connor LH; Vogler CA; Roberts M; Walkley S; Levy B; Daly TM; Sands MS
    Mol Ther; 2001 Mar; 3(3):351-8. PubMed ID: 11273777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
    Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
    Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
    Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
    Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors.
    Bosch A; Perret E; Desmaris N; Heard JM
    Mol Ther; 2000 Jan; 1(1):63-70. PubMed ID: 10933913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for murine mucopolysaccharidosis type VII.
    Sands MS; Wolfe JH; Birkenmeier EH; Barker JE; Vogler C; Sly WS; Okuyama T; Freeman B; Nicholes A; Muzyczka N; Chang PL; Axelrod HR
    Neuromuscul Disord; 1997 Jul; 7(5):352-60. PubMed ID: 9267850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.